Discover 2,242 paid clinical trials in San Jose, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Jose currently offers many active clinical trials with a particular emphasis on diabetes, Parkinson’s disease, Alzheimer’s disease, and cardiovascular conditions. Whether you’re looking for trials related to a specific health condition or interested in paid research as a healthy volunteer, San Jose’s diverse studies provide a variety of choices to explore new treatments while contributing to the future of medicine.
Filter
2
Filter results
Results: 2,242
A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)
for
Narcolepsy Type 2
Location: Redwood City CA, Santa Ana CA, Chula Vista CA,
Sponsor: Takeda
Sex: All
Age: 18 - 70
Code: NCT06952699
Phase 2, Recruiting
Panitumumab-IRDye800 to Detect Pediatric Neoplasms During Neurosurgical Procedures
for
Brain Tumor
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 0 - 25
Code: NCT04085887
Phase 1, Phase 2, Recruiting
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
for
Breast Neoplasms, Neoplasm Metastasis
Location: Palo Alto CA, Emeryville CA, Greenbrae CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18+
Code: NCT07174336
Phase 3, Recruiting
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
for
Pediatric Migraine
Location: Walnut Creek CA, Fresno CA, Long Beach CA, Pomona CA,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04649242
Phase 3, Recruiting
Testing the Addition of Chemotherapy or Chemo-Immunotherapy to the Usual Surgery for Advanced Head and Neck Cancer
for
Clinical Stage II HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8,
Location: Palo Alto CA, Sacramento CA, Los Angeles CA, Orange CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT07195734
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Study to Assess BMS-986460 in Participants With Metastatic Castration-resistant Prostate Cancer
for
Metastatic Castration-resistant Prostate Cancer
Location: Palo Alto CA, Seattle WA, San Antonio TX, Durham NC,
Sponsor: Bristol-Myers Squibb
Sex: Male
Age: 18+
Code: NCT06067841
Phase 1, Recruiting
Testing the Addition of Paclitaxel Administered Into the Abdominal Cavity Combined With Chemotherapy for Patients With Gastric Cancer Spread to the Abdominal Cavity
for
Gastric Adenocarcinoma,
Location: Palo Alto CA, Los Angeles CA, Orange CA, Irvine CA,
Sponsor: ECOG-ACRIN Cancer Research Group
Sex: All
Age: 18+
Code: NCT07001748
Phase 2, Phase 3, Recruiting
A Study to Investigate Sonrotoclax (BGB-11417) Plus Zanubrutinib (BGB-3111) Compared With Venetoclax Plus Acalabrutinib in Adults With Previously Untreated Chronic Lymphocytic Leukemia
for
Chronic Lymphocytic Leukemia
Location: Palo Alto CA, Duarte CA, Orange CA, Eugene OR,
Sponsor: BeOne Medicines
Sex: All
Age: 18+
Code: NCT07277231
Phase 3, Recruiting
A Study of Mutant Selective-Inhibitor (CGT6297), in Patients With Advanced Solid Tumors
for
PIK3CA Mutations, Advanced Solid Tumors, Adult,
Location: Palo Alto CA, Los Angeles CA, West Valley City UT,
Sponsor: Cogent Biosciences, Inc.
Sex: All
Age: 18+
Code: NCT07383506
Phase 1, Recruiting
A Study of Neoadjuvant Amivantamab With Either Lazertinib or Chemotherapy in Participants With Resectable EGFR-Mutated NSCLC
for
Carcinoma, Non-Small-Cell Lung
Location: Stanford CA, Duarte CA, Irvine CA, Portland OR, Toronto,
Sponsor: Janssen Research & Development, LLC
Sex: All
Age: 18+
Code: NCT07586202
Phase 2, Recruiting
A Randomized Study of ASTX727 With or Without Iadademstat in Advanced Myeloproliferative Neoplasms (MPNs)
for
Accelerated Phase Myeloproliferative Neoplasm,
Location: Palo Alto CA, Sacramento CA, Orange CA, Irvine CA,
Sponsor: National Cancer Institute (NCI)
Sex: All
Age: 18+
Code: NCT06661915
Phase 2, Recruiting
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
for
Breast Cancer
Location: Palo Alto CA, Reno NV, Solvang CA, Santa Barbara CA,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07062965
Phase 3, Recruiting
Vismodegib, FAK Inhibitor GSK2256098, Capivasertib, and Abemaciclib in Treating Patients With Progressive Meningiomas
for
Intracranial Meningioma, Recurrent Meningioma,
Location: Stockton CA, Merced CA, Elk Grove CA, Sacramento CA,
Sponsor: Alliance for Clinical Trials in Oncology
Sex: All
Age: 18+
Code: NCT02523014
Phase 2, Recruiting
VO and Nivolumab vs Physician's Choice in Advanced Melanoma That Progressed on Anti-PD-1 & Anti-CTLA-4 Drugs [IGNYTE-3]
for
Advanced Melanoma
Location: Palo Alto CA, San Francisco CA, Los Angeles CA,
Sponsor: Replimune, Inc.
Sex: All
Age: 12+
Code: NCT06264180
Phase 3, Recruiting
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
for
Acute Treatment of Migraine
Location: Walnut Creek CA, Fresno CA, Long Beach CA, Pomona CA,
Sponsor: Pfizer
Sex: All
Age: 6 - 17
Code: NCT04743141
Phase 3, Recruiting
Neratinib and Fam-Trastuzumab Deruxtecan in Advanced Gastro-esophageal Cancer Patients
Location: Palo Alto CA, Buffalo NY, Philadelphia PA
Sponsor: Fox Chase Cancer Center
Sex: All
Age: 18+
Code: NCT05274048
Phase 1, Recruiting
Testing the Addition of Stereotactic Radiation Therapy With Immune Therapy for the Treatment of Patients With Unresectable or Metastatic Renal Cell Cancer, SAMURAI Trial
for
Metastatic Renal Cell Carcinoma,
Location: San Mateo CA, Burlingame CA, San Francisco CA,
Sponsor: NRG Oncology
Sex: All
Age: 18+
Code: NCT05327686
Phase 2, Recruiting
64Cu-SAR-bisPSMA and 67Cu-SAR-bisPSMA for Identification and Treatment of PSMA-expressing Metastatic Castrate Resistant Prostate Cancer (SECuRE)
for
Prostatic Neoplasms, Castration-Resistant
Location: Stanford CA, Omaha NE, Rochester MN, St Louis MO,
Sponsor: Clarity Pharmaceuticals Ltd
Sex: Male
Age: 18+
Code: NCT04868604
Phase 1, Phase 2, Recruiting
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Location: Palo Alto CA, Oakland CA, Los Angeles CA, Denver CO,
Sponsor: M.D. Anderson Cancer Center
Sex: All
Age: 0 - 17
Code: NCT06651580
Recruiting
Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Tuspetinib (HM43239) in Patients With Relapsed or Refractory Acute Myeloid Leukemia